SLC5A1 and diabetes mellitus: A role of SGLT1 and 2 in diabetes-related endothelial dysfunction is also supported by the fact that high glucose promoted premature senescence and pro-atherothrombotic responses in ECs and that this effect is inhibited by empagliflozin and associated with an up-regulation of the expression level of SGLT1 and 2 [28].